Max Jaderberg appointed President of Isomorphic Labs
Isomorphic Labs →Isomorphic Labs announced that Max Jaderberg would become President effective 1 January 2026, moving from his position as Chief AI Officer. The announcement said Colin Murdoch would step down as President after leading the company through its early development. Jaderberg was described as a founding team member who built the company’s approach to artificial intelligence and led development of its drug-design engine. His work involved applying AI to chemical space, difficult biological targets and new drug candidates. The announcement date is distinct from the effective appointment date. The current leadership roster subsequently identifies Jaderberg as President, supporting completion of the announced transition.